274 related articles for article (PubMed ID: 11150373)
21. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
22. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes.
Feuillard J; Dargemont C; Ferreira V; Tarantino N; Debré P; Raphael M; Körner M
J Immunol; 1997 Mar; 158(6):2585-91. PubMed ID: 9058790
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine.
Liptay S; Bachem M; Häcker G; Adler G; Debatin KM; Schmid RM
Br J Pharmacol; 1999 Dec; 128(7):1361-9. PubMed ID: 10602313
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.
Gu X; Wang Y; Zhang G; Li W; Tu P
J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
[TBL] [Abstract][Full Text] [Related]
26. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
[TBL] [Abstract][Full Text] [Related]
27. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
[TBL] [Abstract][Full Text] [Related]
28. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
Rundall BK; Denlinger CE; Jones DR
Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
30. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I.
Meng Z; Lou S; Tan J; Xu K; Jia Q; Zheng W
PLoS One; 2012; 7(3):e33597. PubMed ID: 22438958
[TBL] [Abstract][Full Text] [Related]
32. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
34. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
[TBL] [Abstract][Full Text] [Related]
35. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
[TBL] [Abstract][Full Text] [Related]
36. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
[TBL] [Abstract][Full Text] [Related]
37. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Beg AA; Baldwin AS
Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis.
Fujihara S; Ward C; Dransfield I; Hay RT; Uings IJ; Hayes B; Farrow SN; Haslett C; Rossi AG
Eur J Immunol; 2002 Feb; 32(2):457-66. PubMed ID: 11813164
[TBL] [Abstract][Full Text] [Related]
39. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
40. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.
Lee H; Arsura M; Wu M; Duyao M; Buckler AJ; Sonenshein GE
J Exp Med; 1995 Mar; 181(3):1169-77. PubMed ID: 7869034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]